INTS – intensity therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate
Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 [Yahoo! Finance]
Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
Form 8-K INTENSITY THERAPEUTICS, For: May 06
Form 8-K INTENSITY THERAPEUTICS, For: May 09
Form 10-Q INTENSITY THERAPEUTICS, For: Mar 31
Form 8-K INTENSITY THERAPEUTICS, For: Apr 18
Form 8-K INTENSITY THERAPEUTICS, For: Mar 14
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.